These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12141739)

  • 1. Prophylactic vaccination against Lyme borreliosis for man and dogs and new strategies to treat established B. burgdorferi infections.
    Wallich R; Jahraus O; Simon MM
    Int J Med Microbiol; 2002 Jun; 291 Suppl 33():147-9. PubMed ID: 12141739
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
    Grosenbaugh DA; Rissi DR; Krimer PM
    Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine.
    Straubinger RK; Dharma Rao T; Davidson E; Summers BA; Jacobson RH; Frey AB
    Vaccine; 2001 Oct; 20(1-2):181-93. PubMed ID: 11567763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lyme borreliosis--vaccines in the "pipeline"].
    Kramer M
    MMW Fortschr Med; 1999 Jun; 141(25):52-3. PubMed ID: 10897909
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT
    Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT; Rose CD; Budd SM; Gibney KM
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against Lyme borreliosis.
    Wahlberg P
    Ann Med; 1999 Aug; 31(4):233-5. PubMed ID: 10480752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More on diagnosis of canine borreliosis.
    Sonneborn-Turetsky JH
    J Am Vet Med Assoc; 1993 Dec; 203(11):1521-2. PubMed ID: 8288468
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
    Fikrig E; Telford SR; Wallich R; Chen M; Lobet Y; Matuschka FR; Kimsey RB; Kantor FS; Barthold SW; Spielman A; Flavell RA
    J Exp Med; 1995 Jan; 181(1):215-21. PubMed ID: 7807004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.
    Coughlin RT; Fish D; Mather TN; Ma J; Pavia C; Bulger P
    J Infect Dis; 1995 Apr; 171(4):1049-52. PubMed ID: 7706788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Borrelia burgdorferi outer surface protein A vaccine: importance, role, and value.
    Sigal LH
    J Pediatr; 1999 Nov; 135(5):539-41. PubMed ID: 10547238
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-OspA antibody reduces reservoir competence of mice for Borrelia burgdorferi, the agent of Lyme disease.
    Brunet LR; Katavolos P; Spielman A; Telford SR
    Med Vet Entomol; 1997 Apr; 11(2):198-200. PubMed ID: 9226653
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination as a modality to prevent Lyme disease. A status report.
    Wormser GP
    Infect Dis Clin North Am; 1999 Mar; 13(1):135-48, vii. PubMed ID: 10198796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization against Lyme disease--an important first step.
    Steigbigel RT; Benach JL
    N Engl J Med; 1998 Jul; 339(4):263-4. PubMed ID: 9673306
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
    J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of OspA vaccination on Lyme disease serologic testing.
    Aguero-Rosenfeld ME; Roberge J; Carbonaro CA; Nowakowski J; Nadelman RB; Wormser GP
    J Clin Microbiol; 1999 Nov; 37(11):3718-21. PubMed ID: 10523583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.